Webinars
28 August, 2020
at 8:00 AM
Webinar: Simoa® Planar Technology For Ultra-sensitive Quantification Of Biomarkers In Multiplex: Infectious Diseases And Virology
Paula Perin, Phd - Senior Field Application Scientist, Quanterix Learn More About Groundbreaking Simoa...
19 August 2020
Simoa Planar Technology For Ultra-sensitive Quantification Of Biomarkers In Multiplex: Infectious Diseases And Virology
Paula Perin, Phd - Quanterix Senior Field Application Scientist | August 19, 2020 Learn More About...
14 August 2019
at 12:00PM
Quanterix, Biomarkers For Life: Planar Array Product Overview
Listen in to Quanterix President, Chairman and CEO Kevin Hrusovsky and Senior Vice President of Commercial...
11 June 2020
Cytokine Biomarkers Of Inflammatory Response In Covid-19 Patients
June 11, 2020 Discussions: Ultrasensitive SIMOA™ Immunoassays Impacting COVID-19, Infectious...
24 April 2019
at 11:00 AM
Why Industry Leaders Are Choosing The Simoa® Technology For Phase I – IV Clinical Studies
Listen On Demand Join Dr. Maribeth Raines, Vice President of Laboratory Services at Pacific Biomarkers...
12 December 2018
at 11:00AM
Use Of Simoa Planar Protein Multiplex Arrays As A Sensitive Biomarker Platform In Oncology Clinical Trials
Nature.com Webcasts 8AM PST | 11AM EST | 4PM GMT | 5PM CET Watch On Demand Compared to tissue-based...
21 June 2018
at 11:00AM
Ultra-sensitive Immunoassays: Beyond Biomarkers And Into PK And Immunogenicity
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr....
15 May 2018
at 11:00AM
Ultra-sensitive Detection Of Interferon Alpha Protein In Human Disease By Digital Elisa
Speaker: Dr. Darragh Duffy, Institut Pasteur, ParisModerator: Dr. Jayshan Carpen, Moderator,...
14 September 2017
at 11:00AM
Predicting Progression Of Neurodegeneration With A Blood Test: How Neurofilament Light Protein May Be A Game-changer For Therapeutic Development In Huntington’s Disease
SIMOA technology has facilitated the quantification of neurofilament light (NfL), a brain-derived protein,...